Australia, Aug. 26 -- LPOXY THERAPEUTICS Inc., owns the trademark (2555735) for 'SIDIPREV' till April 17, 2035.
Status: protected:
Registered/protected
Classes: 5 [Antimicrobial preparations for inhibiting bacteria; drug delivery agents in the form of coated capsules that facilitate the delivery of pharmaceutical preparations; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention of autoimmune, inflammatory, bacterial, and antibiotic-induced infectious conditions; pharmaceutical preparations for delivery of oxygen to tissue; therapeutic agents for delivery of oxygen to human tissue.] and 44 [Medical diagnostic services; medical services in the field of antibiotic-induced infection and gastroenterology; providing information in the fields of health and wellness in the field of autoimmune conditions, inflammatory conditions, bacterial conditions, antibiotic-induced infectious conditions, and oxygen therapy via a website; providing medical information in the field of autoimmune conditions, inflammatory conditions, bacterial conditions, antibiotic-induced infectious conditions, and oxygen therapy.]
Type of Mark: Word
Date of Acceptance: June 17
Registration Advertised: Aug. 25
For further details contact Knobbe, Martens, Olson & Bear LLP .
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2555735.
Disclaimer: Curated by HT Syndication.
